Celldex Therapeutics (CLDX) Q4 2019 Earnings

12NovConfirmed
Q1 2019
Q2 2019
Q3 2019
Q4 2019
-1.4
-1.18
-0.97
-0.75

Details

Expected EPS
-0.84
Actual EPS
-0.75
Surprise EPS
0.09
Surprise Percent
+10.71%

Description

Celldex Therapeutics (CLDX) has reported earnings of -0.75 per share for Q4 2019.

0 Comments

Share your thoughts